Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Seaport Therapeutics Inc.

Headquarters: Boston, MA, United States of America
Year Founded: 2024
Status: Private
BioCentury | Nov 6, 2024
Management Tracks

SOBI to propose David Meek as chair

Plus: Seaport hires Lauren White as CFO, and updates from Tarsus and Takeda
BioCentury | Oct 25, 2024
Finance

Septerna’s GPCRs draw strong demand in $288M IPO

BioCentury’s Financial Report: ProQR’s $75M raise, Seaport’s $225M series B and more
BioCentury | Jun 19, 2024
Management Tracks

Seaport adds Loebel as CMO, Gladstein as general counsel

Plus: SpyBiotech names Keith Dewedoff CFO, and updates from Kriya, CytomX and Progentec
BioCentury | May 7, 2024
Management Tracks

Seaport rounds out C-suite with new hires

Plus: Germany-based Topas taps new CEO, and updates from Quest, Nimbus and more
BioCentury | Apr 12, 2024
Finance

Venture report: Torl doubles its series B funding in Deep Track-led B2

Plus: PureTech’s Seaport launches, and updates from Nvelop, D3 Bio and more
BioCentury | Apr 10, 2024
Management Tracks

PureTech’s Zohar takes CEO role at new portfolio company targeting CNS

Plus: AskBio hires former Prevail CSO, and updates from Illumina, Xencor, Adcentrx, enGene and more
BioCentury | Apr 9, 2024
Emerging Company Profile

Karuna team, backers reunite for neuropsychiatry play Seaport’s launch

PureTech’s Zohar, Karuna’s Paul among team advancing prodrug candidates for anxiety and depression that avoid hepatic absorption
Items per page:
1 - 7 of 7
Help Center
Username
Request a Demo
Request Training
Ask a Question